PharmNet Rx - Pharmacy Discount Cards
 

What Is Generic Bioequivalence?

Generics are not required to replicate the extensive clinical trials that have already been used in the development of the original, brand-name drug. These tests usually involve a few hundred to a few thousand patients. Since the safety and efficacy of the brand-name product has already been well established in clinical testing and frequently many years of patient use, it is scientifically unnecessary, and would be unethical, to require that such extensive testing be repeated in human subjects for each generic drug that a firm wishes to market. Instead, generic applicants must scientifically demonstrate that their product is bioequivalent (i.e., performs in the same manner) to the pioneer drug.

One way scientists demonstrate bioequivalence is to measure the time it takes the generic drug to reach the bloodstream and its concentration in the bloodstream in 24 to 36 healthy, normal volunteers. This gives them the rate and extent of absorption—or bioavailability—of the generic drug, which they then compare to that of the pioneer drug. The generic version must deliver the same amount of active ingredients into a patient's bloodstream in the same amount of time as the pioneer drug.

Using bioequivalence as the basis for approving generic copies of drug products was established by the Drug Price Competition and Patent Term Restoration Act of 1984, also known as the Hatch-Waxman Act. Brand-name drugs are subject to the same bioequivalency tests as generics when their manufacturers reformulate them.

<< FDA Ensures Equivalence of Generic Drugs

Prescription Drug Prices
Find Alphabetically:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z#
Search:
Rx Online
Health News & Info

More Pregnant Women Having Heart Attacks
The risk of heart attack among pregnant women increased 25 percent between 2002 and 2014, with the rate rising from 7 to 9.5 for every 100,000 pregnancies in the United States, researcher at the New York University School of Medicine say.

1 in 4 Docs Report Sexual Harassment by Patients
In a recent survey by Medscape, 27% of doctors said they had been sexually harassed by patients in the office, including those who acted in an overtly sexual manner toward the physician; asked for a date; patients who tried to touch, grope, or grab them. In all three categories, the harassment happened more frequently to female physicians.

Shopping Cart
Your cart is empty.
Shopping
»  Personal Care & Bath
»  Diabetic Supplies
»  Home Medical Supplies
»  Diet & Nutrition
»  Vitamins & Supplements
»  Natural Products
»  Sexual Health
»  Baby & Child Care
My Account
Follow Us
Facebook Twitter